Better Medicines for Children, A DIA/EFGCP Conference

Plan ahead and join us to reflect on the importance of two major headways that are currently affecting Paediatric research: Innovative approaches to Drug Development and impact of the current environment on the Regulatory and Research Infrastructure

Back to Agenda

Session 7: Orphan Medicines – Doing Studies in Small Populations

Session Chair(s)

To Be Announced

NA, Switzerland

Geneviève Le Visage, PharmD, MSc

Head EU RA Policy and Liaison

Novartis Pharma AG, Switzerland

Session 7: Orphan Medicines – Doing Studies in Small Populations

Speaker(s)

Feedback on the Joint Review of the Paediatric and Orphan Regulations

Fabio D’Atri

Unit B5 Directorate General for Health and Food Safey, European Commission , Belgium

Policy Officer, Deputy Head of Unit

Orphan Medicines for Paediatric Use - A focus on the European Union

Thomas Kühler, PhD, MSc

Sanofi R&D, France

Head GRSP EU/AMEE

Have an account?

Better Medicines for Children, A DIA/EFGCP Conference

Session 7: Orphan Medicines – Doing Studies in Small Populations

Session Chair(s)

To Be Announced

Geneviève Le Visage, PharmD, MSc

Speaker(s)

Feedback on the Joint Review of the Paediatric and Orphan Regulations

Orphan Medicines for Paediatric Use - A focus on the European Union

Be informed and stay engaged.